Avantor, Inc. (AVTR) Operating Margin
- Operating margin · 12 months: Value -4.49%; Formula and calculation Operating income / revenue. Period ending 2026-03-31..
Operating margin
Overview →Financial period ending 2026-03-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -4.49% | Operating income / revenue. Period ending 2026-03-31. $-294.10M ÷ $6.55B × 100 ≈ -4.49% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -294.10M USD | Operating Income (Loss) |
| Revenue | 6.55B USD | |
| Cost of products and services | 4.45B USD | Cost of Goods and Services Sold |
| Research and development | (m) | |
| Selling, general and administration | 1.61B USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-03-31 | $-294.10M | $6.55B | $4.45B | (m) | $1.61B | -4.49% |
| 2025-12-31 | $-246.20M | $6.55B | $4.41B | (m) | $1.60B | -3.76% |
| 2025-09-30 | $265.50M | $6.58B | $4.40B | (m) | $1.57B | 4.04% |
| 2025-06-30 | $1.04B | $6.67B | $4.45B | (m) | $1.62B | 15.59% |
| 2025-03-31 | $1.09B | $6.69B | $4.44B | (m) | $1.60B | 16.24% |
| 2024-12-31 | $1.08B | $6.78B | $4.50B | (m) | $1.64B | 15.99% |
| 2024-09-30 | $630.00M | $6.82B | $4.53B | (m) | $1.66B | 9.24% |
| 2024-06-30 | $715.60M | $6.83B | $4.52B | (m) | $1.59B | 10.48% |
| 2024-03-31 | $611.50M | $6.87B | $4.56B | (m) | $1.54B | 8.91% |
| 2023-12-31 | $696.40M | $6.97B | $4.60B | (m) | $1.51B | 10.00% |
| 2023-09-30 | $764.90M | $7.04B | $4.63B | (m) | $1.48B | 10.87% |
| 2023-06-30 | $830.50M | $7.18B | $4.70B | (m) | $1.49B | 11.57% |
| 2023-03-31 | $1.05B | $7.34B | $4.80B | (m) | $1.48B | 14.36% |
| 2022-12-31 | $1.13B | $7.51B | $4.91B | (m) | $1.47B | 15.04% |
| 2022-09-30 | $1.09B | $7.63B | $4.99B | (m) | $1.54B | 14.33% |
| 2022-06-30 | $1.05B | $7.60B | $5.00B | (m) | $1.55B | 13.86% |
| 2022-03-31 | $1.01B | $7.55B | $4.97B | (m) | $1.57B | 13.41% |
| 2021-12-31 | $972.20M | $7.39B | $4.88B | (m) | $1.53B | 13.16% |
| 2021-09-30 | $962.80M | $7.27B | $4.83B | (m) | $1.47B | 13.24% |
| 2021-06-30 | $902.80M | $7.04B | $4.71B | (m) | $1.42B | 12.82% |
| 2021-03-31 | $814.70M | $6.66B | $4.47B | (m) | $1.38B | 12.23% |
| 2020-12-31 | $706.80M | $6.39B | $4.31B | (m) | $1.37B | 11.05% |
| 2020-09-30 | $654.10M | $6.13B | $4.15B | (m) | $1.33B | 10.68% |
| 2020-06-30 | $620.10M | $6.03B | $4.08B | (m) | $1.33B | 10.29% |
| 2020-03-31 | $572.60M | $6.08B | $4.13B | (m) | $1.37B | 9.42% |
| 2019-12-31 | $551.80M | $6.04B | $4.12B | (m) | $1.37B | 9.14% |
| 2019-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | $5.93B | (m) | (m) | (m) | (m) |
| 2018-12-31 | $413.50M | $5.86B | $4.04B | (m) | $1.41B | 7.05% |
| 2018-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $-210.40M | $1.25B | $814.60M | (m) | $449.70M | -16.87% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |